Research.Patient.info

Apathy in neurodegenerative disorders research hub

2 indexed studies · 0 currently recruiting

ongoing, recruitingHuman Pharmacology (Phase I)- Other
A single-centre, open-label, phase I trial evaluating the pharmacokinetics of single ascending oral doses of IRL757 in healthy elderly volunteers
This study is looking at a new medicine called IRL757. It's for older, healthy people to see how their bodies handle the medicine, like how much gets into the blood and how long it stays there. This helps us understand it better for people with conditions like apathy.
Sweden
ongoing, recruitingHuman Pharmacology (Phase I)- First administration to humans
A prospective, single-centre, randomised, double-blind, placebo-controlled, phase I, First-In-Human (FIH) trial evaluating the safety and tolerability of single and multiple ascending oral doses of IRL757 in healthy volunteers.
This early-stage study is testing a new medicine called IRL757 in healthy people. It's to check if the medicine is safe and how well people tolerate different doses. The goal is to see if it could eventually help with a condition called apathy, which can affect people with certain brain disorders.
Sweden